OGN smart money
Organon & Co. (OGN): 2 insider buys, 2 Congress trades, 1 top fund holding it, 3 ETF changes in the public filings.
Insider buys, 12 months$855k
Congress buys / sells0 / 2
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-05-07 | Holzbaur Lynette | SVP and Corporate Controller | $353k | $13.35 |
| 2025-11-13 | Cox Carrie Smith | Executive Chair | $502k | $7.67 |
Congress trades
| Filed | Member | Trade | Amount | Traded |
|---|---|---|---|---|
| 2026-08-12 | Kevin Hern | Sell | $1k–$15k | 2026-08-05 |
| 2026-08-10 | Kevin Hern | Sell | $1k–$15k | 2026-08-05 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 86 | Adar1 Capital Management, LLC | 0.01% | $100k |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | TRIM | −$6M | 2026-06-30 |
| Vaneck Pharmaceutical ETF | TRIM | −$800k | 2026-06-30 |
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$600k | 2026-06-30 |